StockOtters
StockOttersSupply Chain Map
Haisco Pharmaceutical Group Co., Ltd. logo

Haisco Pharmaceutical Group Co., Ltd.

002653.SZ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
521
Cost of Revenue
149
Gross Profit
372
Gross Margin
71.5%
Operating Income
71
Operating Margin
13.6%
Net Income
55
Net Margin
10.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
70
EBITDA Margin
13.4%

2023

12/31/2023

Revenue
470
Cost of Revenue
136
Gross Profit
334
Gross Margin
71.1%
Operating Income
44
Operating Margin
9.3%
Net Income
41
Net Margin
8.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
76
EBITDA Margin
16.2%

2022

12/31/2022

Revenue
422
Cost of Revenue
130
Gross Profit
293
Gross Margin
69.3%
Operating Income
51
Operating Margin
12.1%
Net Income
39
Net Margin
9.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
44
EBITDA Margin
10.5%

2021

12/31/2021

Revenue
388
Cost of Revenue
133
Gross Profit
256
Gross Margin
65.9%
Operating Income
72
Operating Margin
18.5%
Net Income
48
Net Margin
12.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
26
EBITDA Margin
6.6%

2020

12/31/2020

Revenue
466
Cost of Revenue
149
Gross Profit
317
Gross Margin
67.9%
Operating Income
98
Operating Margin
21.0%
Net Income
89
Net Margin
19.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
47
EBITDA Margin
10.0%